Comment on Why Investors Are Paying a Premium for These 3 Biotech Stocks

Why Investors Are Paying a Premium for These 3 Biotech Stocks

So far, 2018 has been full of ups and down for the biotech industry as a whole. For these three stocks, though, prices have swung so far in a positive direction that investors are paying huge premiums now. Just one of these companies has an approved product to sell but they're worth a combined $12 billion.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News